Title : More effective DPP4 inhibitors as antidiabetics based on sitagliptin applied QSAR and clinical methods.

Pub. Date : 2014

PMID : 25756669






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Xanthine-based molecules such as serine protease dipeptidyl peptidase 4 (DPP4) inhibitors are compounds often used in improving glycemic control in type 2 diabetic patients and also used for their effects as mild stimulants and as bronchodilators, notably in treating asthma symptoms. Xanthine dipeptidyl peptidase 4 Homo sapiens
2 Xanthine-based molecules such as serine protease dipeptidyl peptidase 4 (DPP4) inhibitors are compounds often used in improving glycemic control in type 2 diabetic patients and also used for their effects as mild stimulants and as bronchodilators, notably in treating asthma symptoms. Xanthine dipeptidyl peptidase 4 Homo sapiens
3 Here, we aim to better understand the molecular features affecting activity of xanthine-based DPP4 inhibitors such as sitagliptin and related compounds and use these features to de novo predict improved sitagliptin derivatives. Xanthine dipeptidyl peptidase 4 Homo sapiens